Credit Agricole S A boosted its position in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 162.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 112,001 shares of the real estate investment trust’s stock after buying an additional 69,400 shares during the period. Credit Agricole S A owned approximately 0.17% of Sabra Healthcare REIT worth $3,128,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of Sabra Healthcare REIT by 14.2% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,799 shares of the real estate investment trust’s stock valued at $106,000 after buying an additional 471 shares in the last quarter. Bank of Montreal Can raised its position in shares of Sabra Healthcare REIT by 44.1% in the first quarter. Bank of Montreal Can now owns 3,893 shares of the real estate investment trust’s stock valued at $109,000 after buying an additional 1,191 shares in the last quarter. Russell Investments Group Ltd. bought a new position in shares of Sabra Healthcare REIT during the fourth quarter valued at about $120,000. Ameritas Investment Partners Inc. bought a new position in shares of Sabra Healthcare REIT during the first quarter valued at about $156,000. Finally, Silvercrest Asset Management Group LLC bought a new position in shares of Sabra Healthcare REIT during the fourth quarter valued at about $232,000. Institutional investors own 99.47% of the company’s stock.

Institutional Ownership by Quarter for Sabra Healthcare REIT (NASDAQ:SBRA)

Sabra Healthcare REIT, Inc. (SBRA) traded up 0.98% on Friday, hitting $23.67. The stock had a trading volume of 2,430,689 shares. The company has a market cap of $1.55 billion, a P/E ratio of 16.36 and a beta of 1.00. The stock’s 50-day moving average is $24.24 and its 200-day moving average is $25.53. Sabra Healthcare REIT, Inc. has a 52-week low of $19.30 and a 52-week high of $29.10.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its quarterly earnings results on Monday, May 8th. The real estate investment trust reported $0.25 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.58 by $0.33. Sabra Healthcare REIT had a net margin of 40.22% and a return on equity of 10.35%. The business had revenue of $62.65 million for the quarter, compared to analysts’ expectations of $63.47 million. The business’s quarterly revenue was up .1% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.54 earnings per share. Analysts expect that Sabra Healthcare REIT, Inc. will post $1.20 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, May 31st. Stockholders of record on Thursday, May 18th were paid a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a dividend yield of 7.27%. This is an increase from Sabra Healthcare REIT’s previous quarterly dividend of $0.42. The ex-dividend date was Tuesday, May 16th. Sabra Healthcare REIT’s dividend payout ratio is 119.45%.

COPYRIGHT VIOLATION WARNING: “Credit Agricole S A Increases Position in Sabra Healthcare REIT, Inc. (SBRA)” was originally posted by Watch List News and is the property of of Watch List News. If you are reading this report on another site, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this report can be viewed at https://www.watchlistnews.com/credit-agricole-s-a-increases-position-in-sabra-healthcare-reit-inc-sbra/1372318.html.

Several research analysts recently issued reports on SBRA shares. Zacks Investment Research raised Sabra Healthcare REIT from a “hold” rating to a “buy” rating and set a $32.00 target price for the company in a research report on Wednesday, April 12th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $30.00 target price on shares of Sabra Healthcare REIT in a research report on Monday, May 8th. Jefferies Group LLC reaffirmed a “hold” rating and set a $28.00 target price on shares of Sabra Healthcare REIT in a research report on Friday, May 12th. Canaccord Genuity reaffirmed a “hold” rating and set a $26.00 target price on shares of Sabra Healthcare REIT in a research report on Tuesday, May 9th. Finally, Stifel Nicolaus raised their target price on Sabra Healthcare REIT from $24.00 to $26.00 and gave the stock a “hold” rating in a research report on Monday, February 27th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the stock. Sabra Healthcare REIT currently has an average rating of “Hold” and an average target price of $27.71.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Healthcare REIT, Inc. (NASDAQ:SBRA).

Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.